CIELITA HALYARD: Open Payments
NPI 1154872919 · GOOSE CREEK, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 46 payments from 18 companies in 2025. Trend: 2023 $1,836 · 2024 $1,671 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $251 |
| PFIZER INC. | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Novo Nordisk Inc | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Amgen Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Astellas Pharma US Inc | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Corcept Therapeutics | 2 | $42 |
Products named: BREZTRI, Kerendia, CAPLYTA, FARXIGA, Wegovy, HETLIOZ, Veozah, ELIQUIS.
Industry payments across SC — which companies pay providers there.
